China Isotope & Radiation Corporation (FRA:5IR)

Market Cap	437.09M -29.2%
Revenue (ttm)	942.41M -4.2%
Net Income	41.95M -21.2%
EPS	0.13 -21.2%
Shares Out	n/a
PE Ratio	9.74
Forward PE	n/a
Dividend	0.04 (3.25%)
Ex-Dividend Date	Oct 23, 2026

Volume	500
Open	1.220
Previous Close	1.280
Day's Range	1.220 - 1.300
52-Week Range	1.220 - 2.480
Beta	n/a
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 27, 2026

About China Isotope & Radiation

China Isotope & Radiation Corporation engages in the research and development, manufacture, and sale of nuclides, diagnostic, and therapeutic radiopharmaceuticals and radioactive source products for medical and industrial applications in China. The company operates through five segments: Nuclear Medicines; Radioactive Source Products; Irradiation; Nuclear Medical Equipment and Related Services; and Other Businesses. The Nuclear Medicines segment engages in research, development, manufacture, and sale of imaging diagnostic and therapeutic radiop...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1983
• Employees: 3,655
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 5IR

Financial Performance

In 2025, China Isotope & Radiation's revenue was 7.19 billion, a decrease of -5.11% compared to the previous year's 7.57 billion. Earnings were 327.43 million, a decrease of -19.48%.

Financial numbers in CNY

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Oct 26, 2026

Data Sources Report a data error